ClinVar Miner

Submissions for variant NM_000249.3(MLH1):c.974G>A (p.Arg325Gln) (rs63750268)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000163500 SCV000214058 likely benign Hereditary cancer-predisposing syndrome 2017-10-11 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Intact protein function observed in appropriate functional assay(s),In silico models in agreement (benign)
Color RCV000163500 SCV000910960 likely benign Hereditary cancer-predisposing syndrome 2016-03-04 criteria provided, single submitter clinical testing
Counsyl RCV000409264 SCV000488009 likely benign Lynch syndrome II 2015-12-11 criteria provided, single submitter clinical testing
GeneDx RCV000216577 SCV000279335 likely benign not specified 2017-10-11 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genetic Services Laboratory, University of Chicago RCV000216577 SCV000595808 likely benign not specified 2017-04-12 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000216577 SCV000917656 uncertain significance not specified 2018-07-13 criteria provided, single submitter clinical testing Variant summary: MLH1 c.974G>A (p.Arg325Gln) results in a conservative amino acid change located in the DNA mismatch repair protein, S5 domain 2-like of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.5e-05 in 246118 control chromosomes. This frequency is not higher than expected for a pathogenic variant in MLH1 causing Lynch Syndrome (4.5e-05 vs 0.00071), allowing no conclusion about variant significance. c.974G>A has been reported in the literature in individuals affected with Lynch Syndrome, including two families in which the variant appears to segregate with disease (two affected patients per family carrying the variant; Borras_2012, Castillejo_2014). These reports do not provide unequivocal conclusions about association of the variant with Lynch Syndrome. Suggesting a benign impact, functional studies including splicing assay, MMR assay, MLH1 expression and PMS2 expression, and MLH1 and PMS2 subcellular localization show the variant to have function similar to WT (Borras_2012). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, five of which classify the variant as likely benign. Based on the evidence outlined above, the variant was classified as a VUS - possible benign variant.
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000075949 SCV000106968 likely benign Lynch syndrome 2013-09-05 reviewed by expert panel research Multifactorial likelihood analysis posterior probability 0.001-0.049
Invitae RCV000524326 SCV000253148 likely benign Hereditary nonpolyposis colon cancer 2017-12-28 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000216577 SCV000601420 uncertain significance not specified 2017-06-28 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.